Travere Therapeutics
TVTX
TVTX
137 hedge funds and large institutions have $1.42B invested in Travere Therapeutics in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 40 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+4
Holders Change %
+3.01%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
28
Increased
48
Reduced
40
Closed
22
Calls
$3.51M
Puts
$4.49M
Net Calls
-$978K
Net Calls Change
-$2.1M
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$35.9M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$26.8M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$13M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$12.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$11.6M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$35.5M |
| 2 |
SCM
Scopia Capital Management
New York
|
-$16.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$13M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$12M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.5M |
